4.7 Article

Probability of Transmission of Malaria from Mosquito to Human Is Regulated by Mosquito Parasite Density in Naive and Vaccinated Hosts

期刊

PLOS PATHOGENS
卷 13, 期 1, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.ppat.1006108

关键词

-

资金

  1. UK Medical Research Council (MRC)/UK Department for International Development (DFID) under MRC/DFID Concordat
  2. PATH Malaria Vaccine Initiative [MR/N00227X/1]
  3. Medical Research Council [MR/K010174/1B, G1002284, MR/N00227X/1] Funding Source: researchfish
  4. National Institute for Health Research [NF-SI-0514-10158, NF-SI-0509-10233] Funding Source: researchfish
  5. Wellcome Trust [104750/Z/14/Z] Funding Source: researchfish
  6. MRC [MR/N00227X/1, G1002284] Funding Source: UKRI

向作者/读者索取更多资源

Over a century since Ronald Ross discovered that malaria is caused by the bite of an infectious mosquito it is still unclear how the number of parasites injected influences disease transmission. Currently it is assumed that all mosquitoes with salivary gland sporozoites are equally infectious irrespective of the number of parasites they harbour, though this has never been rigorously tested. Here we analyse > 1000 experimental infections of humans and mice and demonstrate a dose-dependency for probability of infection and the length of the host pre-patent period. Mosquitoes with a higher numbers of sporozoites in their salivary glands following blood-feeding are more likely to have caused infection (and have done so quicker) than mosquitoes with fewer parasites. A similar dose response for the probability of infection was seen for humans given a pre-erythrocytic vaccine candidate targeting circumsporozoite protein (CSP), and in mice with and without transfusion of anti-CSP antibodies. These interventions prevented infection more efficiently from bites made by mosquitoes with fewer parasites. The importance of parasite number has widespread implications across malariology, ranging from our basic understanding of the parasite, how vaccines are evaluated and the way in which transmission should be measured in the field. It also provides direct evidence for why the only registered malaria vaccine RTS, S was partially effective in recent clinical trials.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据